Literature DB >> 21199173

Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study.

K Shimizu1, H Ogura, T Asahara, K Nomoto, M Morotomi, Y Nakahori, A Osuka, S Yamano, M Goto, A Matsushima, O Tasaki, Y Kuwagata, H Sugimoto.   

Abstract

BACKGROUND: The gut is an important target organ for injury after severe insult, and resolution of feeding intolerance is crucial for critically ill patients. We investigated gut flora and motility to evaluate the impact of gastrointestinal dysmotility on septic complications in patients with severe systemic inflammatory response syndrome (SIRS).
METHODS: Sixty-three ICU patients with severe SIRS were divided into two groups depending on their intestinal condition. Patients with feeding intolerance comprised patients who had feeding intolerance, defined as ≥ 300 mL reflux from nasal gastric feeding tube in 24 h, and patients without feeding intolerance comprised patients with no feeding intolerance. We compared fecal microflora, incidences of bacteremia, and mortality between these groups. KEY
RESULTS: Analysis of feces showed that patients with feeding intolerance had significantly lower numbers of total obligate anaerobes including Bacteroidaceae and Bifidobacterium, higher numbers of Staphylococcus, lower concentrations of acetic acid and propionic acid, and higher concentrations of succinic acid and lactic acid than those in patients without feeding intolerance (P ≤ 0.05). Patients with feeding intolerance had higher incidences of bacteremia (86%vs 18%) and mortality (64%vs 20%) than did patients without feeding intolerance (P ≤ 0.05). CONCLUSIONS & INFERENCES: Gut flora and organic acids were significantly altered in patients with severe SIRS complicated by gastrointestinal dysmotility, which was associated with higher septic mortality in SIRS patients.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21199173     DOI: 10.1111/j.1365-2982.2010.01653.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  21 in total

1.  Japanese apricot improves symptoms of gastrointestinal dysmotility associated with gastroesophageal reflux disease.

Authors:  Takao Maekita; Jun Kato; Shotaro Enomoto; Takeichi Yoshida; Hirotoshi Utsunomiya; Hideyuki Hayashi; Toshiko Hanamitsu; Izumi Inoue; Yoshimasa Maeda; Kosaku Moribata; Yosuke Muraki; Naoki Shingaki; Hisanobu Deguchi; Kazuki Ueda; Mikitaka Iguchi; Hideyuki Tamai; Masao Ichinose
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 2.  Can the intestinal dysmotility of critical illness be differentiated from postoperative ileus?

Authors:  Kirk A Caddell; Robert Martindale; Stephen A McClave; Keith Miller
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 3.  Nutrition of the critically ill - emphasis on liver and pancreas.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

Review 4.  Sepsis and the Microbiome: A Vicious Cycle.

Authors:  William D Miller; Robert Keskey; John C Alverdy
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

5.  Prognostic impact of fecal pH in critically ill patients.

Authors:  Akinori Osuka; Kentaro Shimizu; Hiroshi Ogura; Osamu Tasaki; Toshimitsu Hamasaki; Takashi Asahara; Koji Nomoto; Masami Morotomi; Yasuyuki Kuwagata; Takeshi Shimazu
Journal:  Crit Care       Date:  2012-07-10       Impact factor: 9.097

6.  Daily laxative therapy reduces organ dysfunction in mechanically ventilated patients: a phase II randomized controlled trial.

Authors:  Rodrigo Palacio de Azevedo; Flávio Geraldo Resende Freitas; Elaine Maria Ferreira; Luciano Cesar Pontes de Azevedo; Flávia Ribeiro Machado
Journal:  Crit Care       Date:  2015-09-16       Impact factor: 9.097

7.  454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.

Authors:  Stefan Roos; Johan Dicksved; Valentina Tarasco; Emanuela Locatelli; Fulvio Ricceri; Ulf Grandin; Francesco Savino
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 8.  Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective.

Authors:  Kentaro Shimizu; Hiroshi Ogura; Takashi Asahara; Koji Nomoto; Masami Morotomi; Osamu Tasaki; Asako Matsushima; Yasuyuki Kuwagata; Takeshi Shimazu; Hisashi Sugimoto
Journal:  Dig Dis Sci       Date:  2012-08-19       Impact factor: 3.199

Review 9.  Nutrition of the critically ill — a 21st-century perspective.

Authors:  Stig Bengmark
Journal:  Nutrients       Date:  2013-01-14       Impact factor: 5.717

Review 10.  Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized Trials.

Authors:  Varsha M Asrani; Harry D Yoon; Robin D Megill; John A Windsor; Maxim S Petrov
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.